how long is the longest duration of follow-up?
10 years
col : main author | no. of patients | duration of follow-up years | linearized rate of infection | actuarial freedom from infective endocarditis row 1 : pavie | 675 | 5 |  | 98.2% for all patients, 97.8% for a row 2 : duncan (a) | 2720 | 6 |  | 97.3% for all patients, 97.4% for a row 3 : ionescu (b) | 1171 | 10 |  | 93.7% for all patients, 94.7% for a row 4 : zhu | 520 | 10 |  | 98% for all patients row 5 : revuelta | 239 | 8 | 0.67% per patient year |  row 6 : garcia-bengochea | 248 | 8 | 0.78% per patient year |  row 7 : holden (c) | 290 | 6 | 1.1% per patient year |  row 8 : bachet (d) | 224 | 6 | 1.6% per patient year |
how long is the longest duration of follow-up?
Main author No. of patients Duration of follow-up years Linearized rate of infection Actuarial freedom from infective endocarditis
Pavie 675 5 98.2% for all patients, 97.8% for aortic, 99% for mitral, 100% for multiple valve replacements
Duncan (A) 2720 6 97.3% for all patients, 97.4% for aortic valves, 97.6% for mitral valves, 96.3% for multiple valve replacement
Ionescu (B) 1171 10 93.7% for all patients, 94.7% for aortic valves, 97.1% for mitral valves, 89.3% for multiple valve replacement
Zhu 520 10 98% for all patients
Revuelta 239 8 0.67% per patient year
Garcia-Bengochea 248 8 0.78% per patient year
Holden (C) 290 6 1.1% per patient year
Bachet (D) 224 6 1.6% per patient year
10 years